Novel adipocytokines and its relationship with insulin resistance;Adipocitoquinas Nóveles y su Interrelación en el Fenómeno de Resistencia a la Insulina

Informe Medico

Volumn 11, Issue 11, 2009, Pages 583-588

  Lima, Marcos M ^a   Rosa, Francisco ^a   Marin, Abigail ^a   Balladares, Nathalie ^a   Guerra, Ernesto ^a   Nuccio, Ana G ^b  

^a Universidad de Oriente Nucleo Bolivar   (Venezuela)

^b Hospital IVSS Hector Nouel Joubert   (Venezuela)

Author keywords

Adipocyte; Adipocytokines; Insulin resistance

Indexed keywords

EID: 79953686523     PISSN: 13169688     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Lihn A, Pedersen S, Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obesity reviews 2005;6:13-21.
2. Lima M, Rosa F, Marin A. Síndrome metabólico y adiponectina. Informed 2008;10:195-201.
3. Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007;148:4687-4694. (Pubitemid 47481514)
4. Cash JL, Hart R, Russ A, Dixon J, Colledge W, Doran J, et al. Synthetic chemerin-derived peptides suppress inflammation through Chem R23. J Exp Med 2008;205:767-775. (Pubitemid 351549876)
5. Goralski K, McCarthy T, Hanniman E, Zabel B, Butcher E, Parlee S, et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 2007; 282: 28175-28188. (Pubitemid 47529521)
6. Takahashi M, Takahashi Y, Takahashi K, Zolotaryov F, Su Hong K, Kitazawa R, et al. Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS letters 2008;582:573-578.
7. Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, et al. Visceral adipose tissue-derived serine protease inhibitor: A unique insulinsensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 2005;102: 10610-10615. (Pubitemid 41061602)
8. Youn BS, Klöting N, Kratzsch J, Lee N, Woo Park J, Song ES, et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008;57:372-377.
9. Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay S, et al. Metformin decreases the adipokine vaspin in overweigh women with polycystic ovarian syndrome concomitant with improvement in insulin sentivity and a decrease in insulin resistance. Diabetes 2008;57:1501-1507.
10. Rongvaux A, Shea R, Mulks M, Gigot D, Urbain J, Leo O, et al. PreB-cell colony - enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol 2002; 32:3225-3234. (Pubitemid 35414880)
11. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005;307:426-430. (Pubitemid 40139988)
12. Chen M, Chung F, Chang D, Tsai J, Huang H, Shin S, et al. Elevated plasma level of visfatin/pre-B-cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006;91:295-299. (Pubitemid 43069152)
13. Haider DG, Schindler K, Schaller G, Prager G, Wolzt M, Ludvik B. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 2006;91:1578-1581.
14. Revollo JR, Körner A, Mills K, Satoh A, Wang T, Garten A, et al. Nampt/PBEF/visfatin regulates insulin secretion in ß cells as a systemic NAD biosynthetic enzyme. Cell Metab 2007;6:363-375. (Pubitemid 350011996)
15. Yang Q, Graham T, Mody N, Preitner F, Peroni OD, Zabolotny J, et al. serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-362. (Pubitemid 41065039)
16. Qi Q, Yu Z, Ye X, Zhao F, Huang P, Hu F, et al. Elevated retinolbinding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab 2007;92:4827-4834. (Pubitemid 350223466)
17. Haider DG, Schindler K, Prager G, Bohdjalian A, Luger A, Wolzt M, et al. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 2007; 92: 1168-1171. (Pubitemid 46465698)
18. Lim S, Choi SH, Jeong IK, Kim JH, Moon MK, Park KS, et al. Insulin-sensitizing effects of exercise on adiponectin and retinol-binding protein-4 concentrations in young and middle - aged women. J Clin Endocrinol Metab 2008;93:2263-2268. (Pubitemid 351831545)
19. Balagopal P, Graham T, Kahn B, Altomare A, Funanage V, George D. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J Clin Endocrinol Metab 2007;92:1971-1974. (Pubitemid 46997219)
20. Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen B, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006;290:E1253-E1261. (Pubitemid 43847911)
21. Tan BK, Adya R, Farhatullah S, Lewandowski KC, O'Hare P, Lehnert H, et al. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes 2008; 57:801-808.